.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) gene treatment failing has blown a $230 million ...
.After much more than 20 years of work on neurodegenerative health conditions, Swiss biotech a/c Imm...
.GSK has ditched a phase 2 individual papillomavirus (HPV) injection from its pipe after deciding th...
.Operating system Therapies will note on the NYSE American sell swap today using a $6.4 million IPO ...
.ALX Oncology's period 2 stomach cancer action cost has damaged. After seeing its CD47 blocker easil...
.Another of Ionis Pharmaceuticals' crucial midphase readouts has fallen short of desires, urging the...
.While Biogen's pharma peers are searching for late-stage resources with little bit of danger, CEO C...
.Instil Biography has been a biotech seeking a pipeline after it ditched its lead resources over the...
.Biogen has returned rights to an early Alzheimer's ailment course to Denali Therapeutics, going out...
.Welcome to recently's Chutes & Ladders, our roundup of notable management hirings, shootings as ...